Sign in

CIK 0001664710

  • Non-accelerated filer
  • Smaller reporting company

Keros Therapeutics, Inc.

Sign in to watch
Ticker
KROS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
811173868
Phone
+1 617-314-6297
Business address
1050 WALTHAM STREET, SUITE 302, LEXINGTON, MA, 02421
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$5,619
in 1 filing, $6K under 10b5-1 plans

Net −$5,619. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Prener Anne −$6K Director sold 4% of stake
Date Insider Transaction Shares Price Value Owned after
2021-02-11 Knowles Julius Director Sale −270 $62.79 $17K 458,172
2021-02-11 Knowles Julius Director Sale −2,335 $63.83 $149K 684,916
2021-02-11 Knowles Julius Director Sale −1,526 $63.83 $97K 456,646
2021-02-11 Knowles Julius Director Sale −1,461 $64.87 $95K 683,455
2021-02-11 Knowles Julius Director Sale −952 $64.87 $62K 455,694
2021-02-11 Knowles Julius Director Sale −2,418 $65.80 $159K 681,037
2021-02-11 Knowles Julius Director Sale −1,575 $65.80 $104K 454,119
2021-02-11 Knowles Julius Director Sale −316 $66.65 $21K 680,721
2021-02-11 Knowles Julius Director Sale −206 $66.65 $14K 453,913
2021-02-11 Knowles Julius Director Sale −53 $67.99 $4K 680,668
2021-02-11 Knowles Julius Director Sale −35 $67.98 $2K 453,878
2021-02-11 Ordonez Claudia Chief Medical Officer Exercise or conversion +1,000 $0.48 $480 1,000
2021-02-11 Ordonez Claudia Chief Medical Officer Sale −175 $63.10 $11K 825
2021-02-11 Ordonez Claudia Chief Medical Officer Sale −312 $64.17 $20K 513
2021-02-11 Ordonez Claudia Chief Medical Officer Sale −216 $65.35 $14K 297
2021-02-11 Ordonez Claudia Chief Medical Officer Sale −295 $66.19 $20K 2
2021-02-11 Ordonez Claudia Chief Medical Officer Sale −2 $68.05 $136 0
2021-02-11 Ordonez Claudia Chief Medical Officer Exercise or conversion · Employee Stock Option (right to buy) −1,000 102,211
2021-02-11 Lachey Jennifer Chief Scientific Officer Exercise or conversion +5,300 $0.30 $2K 33,291
2021-02-11 Lachey Jennifer Chief Scientific Officer Sale −447 $62.85 $28K 32,844

Page 28 of 36 · 707 trades